Viela Bio, Inc. Made Headway

Mon, Feb 01, 2021 at 05:33 PM
Viela Bio, Inc. Made Headway

Viela Bio, Inc. (VIE:NASDAQ) shot up at $52.81, a gain of 52.3%. On Fri 29 Jan 21, VIE:NASDAQ hit a New 2-Week Intraday Low of $33.78. The stock appeared on our News Catalysts scanner on Mon 01 Feb 21 at 02:57 PM in the 'INVESTOR UPDATE' category. From Fri 15 Jan 21, the stock recorded 22.22% Up Days and 30.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Viela Bio, Inc. (VIE:NASDAQ)

Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.